Product details

Quadra Logic Technologies received the news that a first generation photodynamic therapy compound owned by Johnson and Johnson would be for sale in the next few days. J & J was in the process of approaching potential buyers - major pharmaceutical firms like Ciba-Geigy, Kodak, and American Cyanamid - to discuss their interest in acquiring it. If Quadra Logic can acquire this technology, they would be able to accelerate their own product development, and be assured the position of world leader in photodynamic therapy development. Quadra Logic management must decide quickly whether to proceed.